Evidence map›Paper›PMID 26142103›Full record

ArticleAIDS and behavior2016

Which Patient Characteristics Among Cocaine Users with HIV Relate to Drug Use and Adherence Outcomes Following a Dual-Focused Intervention?

Gaia Read, Karen S Ingersoll

Open access · greenAbstract read
In one paragraph

Article in AIDS and behavior, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Gaia ReadDepartment of Psychiatry and Neurobehavioral Sciences, School of Medicine, University of Virginia, 310 Old Ivy Way, Suite 102, Charlottesville, VA, 22903, USA.
Karen S IngersollDepartment of Psychiatry and Neurobehavioral Sciences, School of Medicine, University of Virginia, 310 Old Ivy Way, Suite 102, Charlottesville, VA, 22903, USA. kareningersoll@virginia.edu.
University of Virginia · US

Funding

Development of CART for HIV adherence and cocaine abuseR01DA016554 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI INGERSOLL, KAREN S · 2003 to 2006
$1.5M
NIDA NIH HHS R01 DA016554
6 · The paper itself

Abstract

This is a secondary analysis of data from a randomized trial of dually-focused interventions for nonadherent HIV patients with cocaine use disorders (Ingersoll et al. in Drug Alcohol Depend 116(1-3):177-187, 2011). We examined the relationships among baseline demographic, psychological, psychiatric, and behavioral characteristics and 6-months post-study ART adherence, log viral load (VL), ASI Drug Composite Score, and days using cocaine. We used the SAS GLMSELECT procedure to build multivariate models of each post-study outcome. Post-study ART adherence was related to 2 psychological variables; while logVL was related to 2 drug-related behaviors. ASI Drug Composite score was related to 2 psychiatric disorders, 1 demographic, and 1 psychological variable; in contrast, days using cocaine related to 1 behavioral and 3 psychological variables. Analyses show clear, robust relationships among behavioral, psychological and psychiatric diagnosis factors with post-study ART adherence and cocaine use outcomes. Future ART adherence interventions for cocaine users should consider tailoring to these patient characteristics.

Indexed as

Drug MonitoringAdultAnti-Retroviral AgentsCocaine-Related DisordersCrack CocaineFemaleHIV InfectionsHumansMaleMiddle AgedRandomized Controlled Trials as TopicSocioeconomic FactorsTreatment OutcomeAnti-Retroviral AgentsCrack CocaineART adherenceCrack cocainePatient characteristics

Identifiers

PMID26142103
PMCPMC4699872
OpenAlexW792114095

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.